The present invention provides novel compounds that demonstrate protective effects on target cells from HIV infection in a manner as to bind to a chemokine receptor, and which affect the binding of a natural ligand or chemokine to a receptor, such as CXCR4 of a target cell.
本发明提供了一种新型化合物,它们以与
趋化因子受体结合的方式对目标细胞表现出保护效应,并影响天然
配体或
趋化因子与目标细胞的受体(如CXCR4)的结合。